MDMA has become notorious as an illegal dance drug – but the evidence supporting its approval as a treatment for post-traumatic stress disorder (PTSD) in combination with psychotherapy is m
Lundbeck has announced plans to cut its research and development team, which could lead to a reduction of up to 160 jobs from an 800-strong department.
Sweden's Orexo has announced it has bought the exclusive US rights to GAIA’s deprexis, a digital therapy to help patients manage their symptoms of depression and one of the most researched
As the number of coronavirus cases in the world exceeds 1.4 million, the pharma industry is pushing to find new drugs, therapies and tests in the effort to bring the pandemic under control.
A mental health app for young people has seen a spike of 168% during the COVID-19 coronavirus outbreak – and as a result of the increased demand is now freely available to young people acro
In the age of smartphones and virtual reality, NHS trusts must evolve their approach to reach patients, and can look towards a future of clinically proven personalised digital therapeutic t